Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical amphotericin B for chronic sinusitis with polyposis
IRCT20101130005280N42Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of amphotericin b in rhinosinusitis and chronic rhinosinusitis with nasal polyps (CRSwNP) (2 arms), sponsored by Mashhad University of Medical Sciences. Primary endpoints: Clinical status based on Land Criteria and Polyp status on endoscopic findings. Started Oct 2021; status: completed.
02
Drugs
amphotericin b
03
Conditions
rhinosinusitischronic rhinosinusitis with nasal polyps (CRSwNP)
Beyond the preview
Go deeper on IRCT20101130005280N42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20101130005280N42.